Durable response of cutaneous squamous cell carcinoma following high-dose peri-lesional injections of Viscum album extracts-A case report

Phytomedicine

Volumn 20, Issue 3-4, 2013, Pages 324-327

  Werthmann, Paul Georg ^a   Sträter, Gregor ^b   Friesland, Hedda ^b   Kienle, Gunver Sophia ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b General Practitioner   (Germany)

Author keywords

Case report; Cutaneous squamous cell carcinoma; Mistletoe; Viscum

Indexed keywords

VISCUM ALBUM EXTRACT; VISCUM ALBUM LECTIN;

AGED; ARTICLE; CANCER SIZE; CASE REPORT; DRUG ISOLATION; FEMALE; HUMAN; HUMAN TISSUE; INJECTION SITE EDEMA; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN BIOPSY; SKIN CARCINOMA; TREATMENT REFUSAL; TREATMENT RESPONSE; VISCUM ALBUM;

AGED; CARCINOMA, SQUAMOUS CELL; FACIAL NEOPLASMS; HUMANS; INJECTIONS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; VISCUM ALBUM;

EID: 84873585064     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2012.11.001     Document Type: Article

References (29)

1. S.S. Alessi, J.A. Sanches, W.R. Oliveira, M.C. Messina, E.R. Pimentel, and N.C. Festa Treatment of cutaneous tumors with topical 5% imiquimod cream Clinics (Sao Paulo) 64 2009 961 966
2. A. Büssing Mistletoe. The Genus Viscum 2000 pp. 1-265
3. Z. Chodorowski, J.S. Anand, M. Wisniewski, M. Madalinski, K. Wierzba, and J. Wisniewski Spontaneous regression of cancer - review of cases from 1988 to 2006 Przeglad Lekarski 64 2007 380 382
4. D.R. English, B.K. Armstrong, A. Kricker, M.G. Winter, P.J. Heenan, and P.L. Randell Demographic characteristics, pigmentary and cutaneous risk factors for squamous cell carcinoma of the skin: a case-control study International Journal of Cancer 76 1998 628 634
5. S. Farasat, S.S. Yu, V.A. Neel, K.S. Nehal, T. Lardaro, M.C. Mihm, D.R. Byrd, C.M. Balch, J.A. Califano, A.Y. Chuang, W.H. Sharfman, J.P. Shah, P. Nghiem, C.C. Otley, A.P. Tufaro, T.M. Johnson, A.J. Sober, and N.J. Liegeois A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics Journal of the American Academy of Dermatology 2011
6. G.E. Goodman, I. Hellstrom, L. Brodzinsky, C. Nicaise, B. Kulander, D. Hummel, and K.E. Hellstrom Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer Journal of Clinical Oncology 8 1990 1083 1092
7. M.R. Karagas, T.A. Stukel, E.R. Greenberg, J.A. Baron, L.A. Mott, and R.S. Stern Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group JAMA 267 1992 3305 3310
8. G.S. Kienle, R. Grugel, and H. Kiene Safety of higher dosages of Viscum album L. in animals and humans-systematic review of immune changes and safety parameters BMC Complementary and Alternative Medicine 11 2011 72
9. Kienle, G.S., Kiene, H., 2003a. Die Mistel in der Onkologie - Fakten und konzeptionelle Grundlagen.
10. G.S. Kienle, and H. Kiene Wirksamkeitsbeurteilung der Misteltherapie Methodologie und Einzelfälle 1 2003 433 490
11. G.S. Kienle, and H. Kiene Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts European Journal of Medical Research 12 2007 103 119
12. G.S. Kienle, and H. Kiene Influence of Viscum album L. (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies Integrative Cancer Therapies 9 2010 142 157
13. A. Kirsch Successful treatment of metastatic malignant melanoma with Viscum album extract (Iscador M) Journal of Alternative and Complementary Medicine 13 2007 443 445
14. V. Madan, J.T. Lear, and R.M. Szeimies Non-melanoma skin cancer Lancet 375 2010 673 685
15. R. Marks The epidemiology of non-melanoma skin cancer: who, why and what can we do about it Journal of Dermatology 22 1995 853 857
16. R. Mistry, B. Wademan, G. Avery, and S.T. Tan A case of misdiagnosed squamous cell carcinoma due to alternative medical misadventure - time for tightening regulation? New Zealand Medical Journal 123 2010 61 67
17. A. Molassiotis, P. Fernadez-Ortega, D. Pud, G. Ozden, J.A. Scott, V. Panteli, A. Margulies, M. Browall, M. Magri, S. Selvekerova, E. Madsen, L. Milovics, I. Bruyns, G. Gudmundsdottir, S. Hummerston, A.M. Ahmad, N. Platin, N. Kearney, and E. Patiraki Use of complementary and alternative medicine in cancer patients: a European survey Annals of Oncology 16 2005 655 663
18. R.J. Motley, P.W. Preston, and C.M. Lawrence Multiprofessional Guidelines for the Management of the Patient with Primary Cutaneous Squamous Cell Carcinoma 2009
19. B. O'Regan, and C. Hirshberg Spontaneous Remission: An Annotated Bibliography 1993
20. O. Olaku, and J.D. White Herbal therapy use by cancer patients: a literature review on case reports European Journal of Cancer 2010
21. M. Orange, M. Fonseca, A. Lace, B. von Laue, and S. Geider Durable tumour responses following primary high-dose induction with mistletoe extracts: two case reports European Journal of Integrative Medicine 1 2010 227
22. M. Orange, A. Lace, M. Fonseca, H.B. von Laue, S. Geider, and G.S. Kienle Durable regression of primary cutaneous B-cell lymphoma following fever-inducing mistletoe treatment-two case reports Global Advances in Health and Medicine 2012 1
23. P.M. Rodust, E. Stockfleth, C. Ulrich, M. Leverkus, and J. Eberle UV-induced squamous cell carcinoma - a role for antiapoptotic signalling pathways British Journal of Dermatology 161 Suppl. 3 2009 107 115
24. D.E. Rowe, R.J. Carroll, and C.L. Day Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection Journal of the American Academy of Dermatology 26 1992 976 990
25. A. Scheffler, H. Mast, S. Fischer, and H.R. Metelmann Komplette Remission eines Mundhöhlenkarzinoms nach alleiniger Mistelbehandlung 1996 pp. 453-466
26. G. Seifert, C. Tautz, K. Seeger, G. Henze, and A. Laengler Therapeutic use of mistletoe for CD30 + cutaneous lymphoproliferative disorder/lymphomatoid papulosis Journal of the European Academy of Dermatology and Venereology 21 2007 558 560
27. G.M. Stein Toxicology of Mistletoe and their Components 2000 pp. 183-194
28. G.M. Stein, and P.A. Berg Adverse Effects During Therapy with Mistletoe Extracts 2000 pp. 195-208
29. B. Wacker, and T. Nagrani Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies Clinical Cancer Research 2007